» Articles » PMID: 6166945

Dopamine Receptor Binding in Inbred Mice: Strain Differences in Mesolimbic and Nigrostriatal Dopamine Binding Sites

Overview
Specialty Science
Date 1981 May 1
PMID 6166945
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Dopamine receptors were examined by Scatchard analysis in the striatal and olfactory tubercle regions of 11 inbred mouse strains. Simultaneous determinations of the binding characteristics of 3H-labeled 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN), a dopaminergic agonist, and [3H]spiroperidol, a dopaminergic antagonist, were examined. Among the 11 strains, the equilibrium dissociation constant (Kd) for agonist binding did not vary in either the striatum or the olfactory tubercle. Similarly, no strain differences were observed in the Kd for spiroperidol in either region, although the Kd for spiroperidol in the olfactory tubercle was uniformly higher than that in the striatum. Measurement of receptor concentrations revealed strain differences of up to 2-fold for both [3H]ADTN and [3H]spiroperidol binding sites. Within each brain region, the densities of agonist and antagonist binding sites correlated significantly. However, between brain regions there was no correlation in the density of agonist or antagonist binding sites, which suggests that mesolimbic and nigrostriatal dopamine neurons may be under independent genetic control. Analysis of [3H]spiroperidol displacement by clofluperol, aceperone, cinanserin, and mianserin in four inbred mouse strains revealed that 88-90% of the striatal spiroperidol sites are dopaminergic, with the remainder being serotonergic. In contrast, 53-66% of the olfactory tubercle [3H]spiroperidol binding sites are dopaminergic and 34-47% are serotonergic. These data suggest that genetic differences in serotonin receptors and dopamine receptors may exist among inbred mouse strains.

Citing Articles

Maturation of shoaling in two zebrafish strains: a behavioral and neurochemical analysis.

Mahabir S, Chatterjee D, Buske C, Gerlai R Behav Brain Res. 2013; 247:1-8.

PMID: 23518435 PMC: 3646909. DOI: 10.1016/j.bbr.2013.03.013.


Strain-specific regulation of striatal phenotype in Drd2-eGFP BAC transgenic mice.

Chan C, Peterson J, Gertler T, Glajch K, Quintana R, Cui Q J Neurosci. 2012; 32(27):9124-32.

PMID: 22764222 PMC: 3461272. DOI: 10.1523/JNEUROSCI.0229-12.2012.


Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains.

Thomsen M, Ralph R, Caine S Exp Clin Psychopharmacol. 2011; 19(5):342-60.

PMID: 21843011 PMC: 3319345. DOI: 10.1037/a0024053.


Lack of genotype effect on D1, D2 receptors and dopamine transporter binding in triple MOP-, DOP-, and KOP-opioid receptor knockout mice of three different genetic backgrounds.

Yoo J, Bailey A, Ansonoff M, Pintar J, Matifas A, Kieffer B Synapse. 2010; 64(7):520-7.

PMID: 20196137 PMC: 4476320. DOI: 10.1002/syn.20757.


Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice.

Ralph R, Caine S Psychopharmacology (Berl). 2006; 191(3):731-9.

PMID: 17019570 DOI: 10.1007/s00213-006-0511-3.


References
1.
Creese I, Burt D, Snyder S . Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. Life Sci. 1975; 17(6):933-1001. DOI: 10.1016/0024-3205(75)90454-3. View

2.
KETY S, Rosenthal D, Wender P, SCHULSINGER F, Jacobsen B . Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic. Behav Genet. 1976; 6(3):219-25. DOI: 10.1007/BF01065721. View

3.
Leysen J, Gommeren W . Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex. Life Sci. 1978; 23(5):447-52. DOI: 10.1016/0024-3205(78)90151-0. View

4.
Creese I, Usdin T, Snyder S . Guanine nucleotides distinguish between two dopamine receptors. Nature. 1979; 278(5704):577-8. DOI: 10.1038/278577a0. View

5.
Peroutka S, Snyder S . Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979; 16(3):687-99. View